glp 1 and thyroid cancer GLP-1 Receptor Agonists Risk Rodent Data and FDA Warning • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence of medullary thyroid carcinoma (MTC). • Based More Thyroid Cancers Found After

Psychiatry 44 OchiaiT.SanoT.NagayamaT.KubotaN.KadowakiT.WakabayashiT.et al (2021)

Parker AE (2025)

In the ACCESS II trial, patients saw placebo-adjusted mean weight loss of about 16.3% (~39 lbs) at the 180 mg dose and 16.0% (~37 lbs) at 240 mg after 44 weeks

By tailoring treatment strategies to individual health profiles and continuously monitoring IGF-1 levels throughout therapy, healthcare providers can enhance the effectiveness of the treatment

A 4mg maintenance dose is under study

However, its complete profile, encompassing safety, efficacy, and optimal dosage, requires further exploration to fully understand and leverage its potential benefits